| mRNA |
XMD15-27 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
4e-07 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
3e-06 |
| mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
| mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0001 |
| mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
-0.16 |
0.0002 |
| mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
| mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.2 |
0.0002 |
| mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0003 |